Article
Polymorphisms in catechol-O-methyltransferase and methylenetetrahydrofolate reductase in relation to the risk of schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Feb 2008
Muntjewerff Jan-Willem, Gellekink Henkjan, den Heijer Martin, Hoogendoorn Mechteld L C, Kahn René S, Sinke Richard J, Blom Henk J
Abstract excerpt
BACKGROUND: Evidence is emerging for the association of aberrant homocysteine-methylation cycle and increased risk of schizophrenia. METHODS: We examined the prevalence of the catechol-O-methyltransferase (COMT) 324G>A (Val108/158Met) and methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphisms in 252 patients with schizophrenia and 405 control subjects. All subjects were of Dutch ancestry. RESULTS: The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
